m+Medelevator.RU
← Поиск публикаций
Biomaterials science · 2026

Antimicrobial zwitterionic hydrogel coatings for kidney disease-associated catheters: current challenges and advances.

СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Ma Ying, Wang Wenjie, Deng Ningyue, Sun Jiping, Lu Wanhong, Zhao Weifeng, Zhao Changsheng

Аннотация

Zwitterionic hydrogel coatings comprise three-dimensional networks of zwitterionic polymers that bear balanced anionic and cationic groups. These coatings exhibit superior hydration capacity, high drug-loading efficiency, excellent biocompatibility, and remarkable salt resistance. As a result, they have demonstrated significant potential for antimicrobial biomedical applications, i.e., wound dressings, drug delivery, and modifications of medical catheters and implants. In particular, in the context of kidney disease-associated catheters, zwitterionic hydrogel coatings display dual antimicrobial mechanisms: bacterial-repelling and bactericidal effects. Special emphasis is placed on smart coatings, including pH-responsive degradation and drug release, charge-switchable zwitterionic monomer applications, and self-healing functionalities. However, the mechanical properties of zwitterionic hydrogel coatings remain suboptimal. This limitation has been effectively mitigated through strategies consisting of crosslinking optimization, monomer modification to create triazole-zwitterionic hydrogels, and the development of multiple crosslinked zwitterionic hydrogel networks. Additionally, this critical review provides a detailed introduction to recently developed versatile adhesion methods, such as mussel-inspired chemistry, interfacial interpenetration and polycation-reinforced surface bridging strategies, for achieving robust hydrogel integration of hydrogels on catheters. Finally, key prospects for advancing catheter coating design toward clinical translation are outlined.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты